Lia Luus

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

Charlotte F. McDonagh, Alexandra Huhalov, Brian D. Harms et al. · Molecular Cancer Therapeutics · 2012 · 274 citations · Full text

Breast Oncology, Antitumor Activity, Immunology +18

Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation

Amarnath Natarajan, Yuhong Guo, Frederick Harbinski et al. · Journal of Medicinal Chemistry · 2004 · 185 citations

Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

Matthew Onsum, Elena Geretti, Violette Paragas et al. · American Journal Of Pathology · 2013 · 105 citations · Full text

Medicine, Pathology, Her2-positive Patients +5

Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation

Han Chen, Yun-Hua Fan, Amarnath Natarajan et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 57 citations

Bioorganic Chemistry, Biochemistry, Medicine +8

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

Walid S. Kamoun, Dmitri B. Kirpotin, Zhaohua Huang et al. · Nature Biomedical Engineering · 2019 · 57 citations

Nanomedicine, Drug Targeting, Nanotherapeutics +11